Google Alert - "LSD1 inhibitor" OR "sickle cell disease" · Scour

Novo Nordisk Rare Disease Wins Add Context To Undervalued Share Price

Bad gut bacteria contribute to bacteremia in hematopoietic stem cell transplant recipients

The HCPFive: Top News for Healthcare Providers from the Week of 04/19

Spring Blood Drive Aims to Collect Donations for Those Who Need Them Most

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle ...

Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory

Meet the 2026 Commencement Speaker: Ted Love, MD - Rush University System for Health

CMS Postpones GLP-1 Pilot, Boston Scientific Cuts Forecast and More

The Pioneers Of Gene Therapy Honored In Two Of This Year's Breakthrough Prizes

Scientists reveal the biological pathways linking childhood trauma to chronic gut pain

Column: Olympia Fields blood drive remembers Kristin Arielle Oliver

Fulcrum Therapeutics Q1 Earnings Call Highlights

Fulcrum Therapeutics Q1 Earnings Call Highlights

FULC: Pociredir showed strong efficacy and safety in sickle cell disease , with cash runway into 2029

The troubling increase of sickle cell disease in Nigeria - Blueprint Newspapers Limited

First Louisiana patient home from sickle cell gene therapy

Fulcrum Therapeutics Reports Positive Pociredir Data in Sickle Cell Disease , Strong Cash ...

FULC: Pociredir showed strong efficacy and safety in sickle cell disease , with pivotal trial ...

Intellia files CRISPR drug after historic phase 3 readout

Fulcrum Therapeutics Q1 2026 Earnings Call: Complete Transcript

Log in to enable infinite scrolling